Neurogenerative Diseases - 27

Schaeverbeke J, Gille B, Adamczuk K, et al. Cerebrospinal fluid levels
of synaptic and neuronal integrity correlate with gray matter volume
and amyloid load in the precuneus of cognitively intact older adults. J
Neurochem. 2019;149(1):139-157.

10.

Wellington H, Paterson RW, Portelius E, et al. Increased CSF
neurogranin concentration is specific to Alzheimer disease.
Neurology. 2016;86(9):829-835.

11.

Khalil M, Teunissen CE, Otto M, et al. Neurofilaments as biomarkers in
neurological disorders. Nature Reviews Neurology. 2018;14(10):577-589.

12.

Poesen K, Van Damme P. Diagnostic and Prognostic Performance of
Neurofilaments in ALS. Front Neurol. 2019;9:1167-1167.

13.

De Schaepdryver M, Goossens J, De Meyer S, et al. Serum
neurofilament heavy chains as early marker of motor neuron
degeneration. Annals of clinical and translational neurology.
2019;6(10):1971-1979.

14.

Poesen K, De Schaepdryver M, Stubendorff B, et al. Neurofilament
markers for ALS correlate with extent of upper and lower motor
neuron disease. Neurology. 2017;88(24):2302.

15.

Steinacker P, Feneberg E, Weishaupt J, et al. Neurofilaments in the
diagnosis of motoneuron diseases: a prospective study on 455
patients. Journal of Neurology, Neurosurgery &amp; Psychiatry.
2016;87(1):12.

16.

De Schaepdryver M, Jeromin A, Gille B, et al. Comparison of
elevated phosphorylated neurofilament heavy chains in serum and
cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Journal of Neurology, Neurosurgery & Psychiatry. 2018;89(4):367.

17.

Li D-W, Ren H, Jeromin A, et al. Diagnostic Performance of
Neurofilaments in Chinese Patients With Amyotrophic Lateral
Sclerosis: A Prospective Study. Front Neurol. 2018;9:726-726.

About the Author
Philipp Arendt received his doctorate in 2016 from
the University of Ghent and is currently global product manager for neurodegenerative diseases at EUROIMMUN. He is the expert for all scientific and product-related questions related to neurodegenerative
diseases both externally and within the company.
Iswariya Venkataraman obtained her doctorate from
the University of Luebeck in 2018 and is now market development manager in the scientific affairs
department of EUROIMMUN. She plays a key role in
expanding the market for EUROIMMUN's neurodegeneration assays in the United States. As part of this
responsibility, she interacts with key opinion leaders
in the field and is building a network to represent
the scientific arm of the company.

Additional Resources
Biomarkers for Neurodegenerative Diseases
Beta-amyloids and Tau (https://www.euroimmun.com/en/products/indications/antigen-nachweise/
alzheimer/beta-amyloid.html)
Neurofilaments (https://www.euroimmun.com/products/indications/antigen-nachweise/neurodegenerative-diseases/amyotrophic-lateral-sclerosis-als/neurofilament.html)
Neurogranin (https://www.euroimmun.com/products/indications/antigen-nach)

https://www.euroimmun.com/en/products/indications/antigen-nachweise/alzheimer/beta-amyloid.html https://www.euroimmun.com/products/indications/antigen-nachweise/neurodegenerative-diseases/amyotrophic-lateral-sclerosis-als/neurofilament.html https://www.euroimmun.com/products/indications/antigen-nachweise/neurodegenerative-diseases/alzheimer/neurogranin.html

Neurogenerative Diseases

Table of Contents for the Digital Edition of Neurogenerative Diseases